Advanced Oncotherapy (AVO) is pleased to announce a newly established synergy collaboration between CERN and Application of Detectors and Accelerators to Medicine SA (“ADAM”).
A team of experts in accelerator and detector technology from CERN founded ADAM with Italian entrepreneur Dr Alberto Colussi in 2007. ADAM aims to capitalise on the know-how and infrastructure that CERN provides to build innovative accelerators for proton therapy and for conventional radiotherapy.
ADAM's research and development activities have focused on two main fields: the design and construction of compact linear accelerators for conventional radiotherapy, and of compact linear accelerators for proton therapy. The next phase of the collaboration, a newly established synergy between ADAM, CERN and AVO will complete the Proton Beam accelerator complex.
“For CERN the transfer of technology and know-how in the medical field is an important part of the impact of basic science on societal issues,” says CERN Director of Accelerators and Technology Steve Myers. “This partnership is a pragmatic way to share our competences and know-how with industrial partners who are able to bring this innovative medical solution to the market.”
Related Files: 2013_04_11 CERN ADAM announcement FINAL
©
